Abstract
Reactive oxygen species (ROS) were shown to play a role in altering blood-brain barrier (BBB) permeability and formation of brain edema induced by trauma and/or ischemia. 2-arachidonoyl glycerol (2-AG), a novel, potent vasodilatory and cytoprotective endocannabinoid has been implicated to act as an antioxidative agent. This study examines: 1) the possible 2-AG modulation of BBB injury and edema formation induced by closed head injury (CHI); and 2) comparable effects between 2-AG and 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TPL), a known antioxidant nitroxide on endothelial Ca2+ and cytoskeletal responses to H2O2 (ROS). 2AG treatment reduced the CHI-induced increase in BBB permeability and brain edema. The endothelial H2O2-stimulated Ca2+ mobilization and cytoskeleton (vimentin) rearrangement was modified by either 2-AG or TPL. These findings provide evidence of 2-AG antioxidant activity and are consistent with the involvement of ROS in the pathomechanism of CHI-induced BBB injury and brain edema.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Beit-Yannai E, Zhang R, Trembovler V, Samuni A, Shohami E (1996) Cerebroprotective effect of stable nitroxide radicals in closed head injury in the rat. Brain Res 717: 22–28
Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami EJ (1996) An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 13: 557–568
Chen Y, McCarron RM, Azzam N, Reutzler C, Lenz FA, Spatz M (2000) Human brain capillary endothelium: 2-Arachidonoglycerol (Endocannabinoid) interacts with Endothelin-1. Circ Res 87: 323–327
Di Marzo V (1998) Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1392: 153–175
Gallily R, Breuer A, Mechoulam R (2000) 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. Eur J Pharmacol 406: R5–7
Gonzales M, Weksler B, Tsuruta D, Goldman RD, Yoon KJ, Hopkinson SB, Flitney FW, Jones JCR (2001) Structure and function of a vimentin-associated matrix adhesion in endothelial cells. Mol Biol Cell 12: 85–100
Haj-Yehia AI, NassarT, Assaf P, Nassar H, Anggard EE (1999) Effects of the superoxide dismutase-mimic compound TEMPOL on oxidant stress-mediated endothelial dysfunction. Antioxid Redox Signal 1: 221–232
Lewan A, Matz P, Chan PH (2000) Free radical pathway in CNS injury. J Neurotrauma 17: 871–890
Lum H, Roebuck KA (2001) Oxidant stress and endothelial cell dysfunction. Am J Physiol 280: C719–C741
McCarron RM, Uematsu S, Merkel N, Long D, Bembry J, Spatz M (1990) The role of arachidonic acid and oxygen radicals on cerebromicrovascular endothelial permeability. Acta Neurochir (Wien) [Suppl] 51: 61–64
Mechoulam R, Spatz M, Shohami E (2002) Endocannabinoids and neuroprotection. Sci STKE 129: RE5
Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413: 527–531
Rak R, Chao DL, Pluta RM, Mitchell JB, Oldfield EH, Watson JC (2000) Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia. J Neurosurg 92: 646–651
Randall MD, Kendall DA (1998) Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol Sci 19: 55–58
Rogers KR, Morris CJ, Blake DR (1991) Oxidation of thiol in the vimentin cytoskeleton. Biochem J 275: 789–791
Spatz M, Kawai N, Merkel N, Bembry J, McCarron RM (1997) Functional properties of cultured endothelial cells derived from large microvessels of human brain. Am J Physiol 272: C231–C239
Sugiura T, Kodaka T, Nakane S, Kishimoto S, Kondo S, Waku K (1998) Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Commun 243: 838–843
Yasuma Y, Strasser A, Ruetzel C, McCarron RM, Spatz M (1997) The effect of nitric oxide inhibition on ischemic brain edema. Acta Neurochir (Wien) [Suppl] 70: 202–205
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Wien
About this paper
Cite this paper
McCarron, R.M. et al. (2003). Antioxidant properties of the vasoactive endocannabinoid, 2-arachidonoyl glycerol (2-AG). In: Kuroiwa, T., et al. Brain Edema XII. Acta Neurochirurgica Supplements, vol 86. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0651-8_59
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0651-8_59
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7220-9
Online ISBN: 978-3-7091-0651-8
eBook Packages: Springer Book Archive